Market Place
Sourcing Support
LB Pharma Names Heather Turner CEO For Schizophrenia Advances
19 Nov 2024 //
GLOBENEWSWIRE
LB Pharmaceuticals closes $75M Series C as it begins PhII schizophrenia trial
24 Jan 2024 //
ENDPTS
LB Pharmaceuticals raising $75M for schizophrenia drug
22 Sep 2023 //
ENDPTS
LB to present Full Results of Dopamine Receptor Occupancy Study of LB-102
07 Dec 2021 //
BUSINESSWIRE
LB Pharma Presents Results of Dopamine Receptor Occupancy Studies of LB-102
04 Oct 2021 //
BUSINESSWIRE
LB Pharma Presents Results of Dopamine Receptor Occupancy Studies of LB-102
04 Oct 2021 //
BUSINESSWIRE
LB Pharma Announces the Initiation of Patient Dosing in Open Label Ph 1b LB-102
02 Feb 2021 //
BUSINESSWIRE
LB Pharmaceuticals Inc Secures $10.0 Million in Additional Financing
25 Sep 2020 //
BUSINESSWIRE
LB Pharmaceuticals Inc Announces Results of LB-102 Phase 1 First-in-Human Study
14 Sep 2020 //
BUSINESSW IRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.